Compass Point Upgrades AthenaHealth To Outperform
Analysts at Compass Point upgraded AthenaHealth, Inc. (NASDAQ: ATHN) from Market Perform to Outperform.
The price target for AthenaHealth has been raised from $134 to $172.
AthenaHealth shares have dropped 1.17% over the past 52 weeks, while the S&P 500 index has gained 15.35% in the same period.
AthenaHealth's shares rose 1.08% to close at $139.85 yesterday.
Latest Ratings for ATHN
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Dec 2018 | Morgan Stanley | Maintains | Equal-Weight | Equal-Weight |
| Nov 2018 | Wells Fargo | Downgrades | Outperform | Market Perform |
| Nov 2018 | Canaccord Genuity | Maintains | Hold | Hold |
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Posted-In: Compass PointUpgrades Analyst Ratings
